Bayer (BAYRY.PK -2%) and Regeneron (REGN -1%) lose their U.K. patent fight on Eylea, a potential...

|About: Bayer A.G. ADR (BAYRY)|By:, SA News Editor

Bayer (BAYRY.PK -2%) and Regeneron (REGN -1%) lose their U.K. patent fight on Eylea, a potential blockbuster VEGF Tarp-Eye treatment produced jointly by the two companies. A London Court has ruled that the drug infringes a patent held by Roche (RHHBY.PK -1.4%) subsidiary Genentech.